SAILIFEPharmaceuticals

Sai Life Sciences LtdQuarterly Results & Earnings

972.00
-1.32%
Profit Growth YoY101.98%Latest quarter
Sales Growth YoY35.88%Latest quarter
Sales CAGR 5Y18.49%5 year compound
Profit CAGR 5Y17.57%5 year compound
📋

Quarterly Performance

YoY Profit Growth+101.98%
🔥 Exceptional growth
YoY Sales Growth+35.88%
🔥 Exceptional growth
OPM 5Y Average
Operating profit margin
19.31%
EPS Growth 5Y
N/A
Interest Coverage
Higher = safer debt servicing
7.88
ROE
11.05%
ROCE
14.05%
💡

Growth Analysis

Sai Life Sciences Ltd reported YoY profit growth of 101.98% and revenue growth of 35.88% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 18.49% and profits at 17.57% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.